Charles Antoine Janssen shares his views on how investments aimed at improving the health of the most vulnerable populations in the world can still generate adequate financial returns for the investors.
Achieving social impact with private capital and hybrid financing models.
Loading Video...
Charles Antoine Janssen is vice chair of UCB, a global biopharmaceutical company headquartered in Belgium. And he's also managing partner of Kois https://koisinvest.com and Healthquad. Charles Antoine has experience in fundraising for social impact funds as well as investing the money raised in companies that want to solve societal problems. He shares his views on how investments aimed at improving the health of the most vulnerable populations in the world can still generate adequate financial returns for the investors.
People:
Oxford Unit:
Keywords:
More in this Series...
The Health Innovation and Entrepreneurship podcast series provides a platform for entrepreneurs to share their vision on how innovation can help solve global health problems and what lessons these entrepreneurs have learnt during their journey. The series draws on the experience from health entrepreneurs around the world and will appeal to health leaders who believe that innovation can increase the number of healthy life years for the populations they serve.